| Mitochondrial aging and age-related dysfunction of mitochondria DA Chistiakov, IA Sobenin, VV Revin, AN Orekhov, YV Bobryshev BioMed research international 2014, 2014 | 421 | 2014 |
| RETRACTED: Macrophage phenotypic plasticity in atherosclerosis: the associated features and the peculiarities of the expression of inflammatory genes DA Chistiakov, YV Bobryshev, NG Nikiforov, NV Elizova, IA Sobenin, ... International journal of cardiology 184, 436-445, 2015 | 193 | 2015 |
| Human miR-221/222 in physiological and atherosclerotic vascular remodeling DA Chistiakov, IA Sobenin, AN Orekhov, YV Bobryshev BioMed research international 2015, 2015 | 174 | 2015 |
| Monocytes as a diagnostic marker of cardiovascular diseases A Gratchev, I Sobenin, A Orekhov, J Kzhyshkowska Immunobiology 217 (5), 476-482, 2012 | 159 | 2012 |
| Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins VV Tertov, IA Sobenin, ZA Gabbasov, EG Popov, AN Orekhov Biochemical and Biophysical Research Communications 163 (1), 489-494, 1989 | 158 | 1989 |
| Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. VV Tertov, IA Sobenin, ZA Gabbasov, EG Popov, O Jaakkola, T Solakivi, ... Laboratory Investigation; a Journal of Technical Methods and Pathology 67 (5 …, 1992 | 139 | 1992 |
| Vascular extracellular matrix in atherosclerosis DA Chistiakov, IA Sobenin, AN Orekhov Cardiology in review 21 (6), 270-288, 2013 | 131 | 2013 |
| Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study IA Sobenin, LV Nedosugova, LV Filatova, MI Balabolkin, TV Gorchakova, ... Acta Diabetologica 45, 1-6, 2008 | 131 | 2008 |
| The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease IA Sobenin, VV Pryanishnikov, LM Kunnova, YA Rabinovich, ... Lipids in health and disease 9 (1), 1-6, 2010 | 128 | 2010 |
| Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. VV Tertov, AN Orekhov, IA Sobenin, ZA Gabbasov, EG Popov, ... Circulation research 71 (1), 218-228, 1992 | 127 | 1992 |
| The atherogenic role of circulating modified lipids in atherosclerosis VI Summerhill, AV Grechko, SF Yet, IA Sobenin, AN Orekhov International journal of molecular sciences 20 (14), 3561, 2019 | 126 | 2019 |
| Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study IA Sobenin, IV Andrianova, ON Demidova, T Gorchakova, AN Orekhov Journal of atherosclerosis and thrombosis 15 (6), 334-338, 2008 | 115 | 2008 |
| Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography VV Tertov, IA Sobenin, AG Tonevitsky, AN Orekhov, VN Smirnov Biochemical and Biophysical Research Communications 167 (3), 1122-1127, 1990 | 108 | 1990 |
| Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes … AN Orekhov, YV Bobryshev, IA Sobenin, AA Melnichenko, DA Chistiakov International journal of molecular sciences 15 (7), 12807-12841, 2014 | 107 | 2014 |
| Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance DA Chistiakov, YV Bobryshev, E Kozarov, IA Sobenin, AN Orekhov Frontiers in microbiology 5, 781, 2015 | 106 | 2015 |
| Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells IA Sobenin, VV Tertov, T Koschinsky, CE Bünting, ES Slavina, II Dedovc, ... Atherosclerosis 100 (1), 41-54, 1993 | 104 | 1993 |
| Direct anti-atherosclerosis-related effects of garlic AN Orekhov, VV Tertov, IA Sobenin, EM Pivovarova Annals of medicine 27 (1), 63-65, 1995 | 102 | 1995 |
| Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein VV Tertov, VV Kaplun, IA Sobenin, EY Boytsova, NV Bovin, AN Orekhov Atherosclerosis 159 (1), 103-115, 2001 | 101 | 2001 |
| Low-density lipoprotein modification occurring in human plasma: Possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification VV Tertov, VV Kaplun, IA Sobenin, AN Orekhov Atherosclerosis 138 (1), 183-195, 1998 | 100 | 1998 |
| Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. AN Orekhov, VV Tertov, IA Sobenin, VN Smirnov, DP Via, J Guevara Jr, ... Journal of lipid research 33 (6), 805-817, 1992 | 100 | 1992 |
